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Abstract 
Hemoglobin A1C measurements are a measure of the average glucose concentrations of a patient 
over three months. This measurement helps provide information about one’s diabetic control, 
meaning if the A1C is higher, their average blood sugar has been higher over the course of the 
past three months. Patients present to providers for preoperative evaluations on a daily basis, and 
many of them have diabetes. It is estimated that over 48.3 million elective surgeries are done in 
the United States every year (Hall et al., 2017). Preoperative evaluation within 30 days of 
surgery is required by most surgeons to better stratify risk versus benefit of the patient’s surgical 
outcomes in that specific setting. It is well documented in the literature that a patients A1C does 
have an impact on their surgical outcome and overall health status. It is important to understand 
their true impact on poor surgical outcomes to provide them with the necessary means to 
decrease this risk.   
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A1C Measurements Impact on Elective Surgeries 
 It is estimated that more than 34 million people in the United States have diabetes, and 
more than 88 million adults in the United States have prediabetes with 80% of those individuals 
not even knowing they have it (CDC, 2019). In 2010, there were over 48.3 billion surgeries done 
annually, which accounts for millions of dollars in healthcare spending as well as a large 
percentage for one of the many specialties (Hall et al., 2017). Current standard of care is that 
patients undergo a preoperative evaluation within 30 days of their surgery. The purpose of this 
practice is to ensure that patients are medically optimized for their surgery and thus reduce their 
surgical risk. In this paper, I will be discussing a research question and its very own literature 
review, as well as the case that this is pertinent too. The case presented in this paper consists of 
an elderly woman who presented for a preoperative evaluation for a right knee arthroscopy. Her 
primary medical history consisted of diabetes type 2, hypertension, hypothyroid, and obesity. It 
was further established that her glycated hemoglobin, or A1C, was 6.2%. Appropriate screening 
prior to approval to proceed with surgery is necessary to establish the least amount of risk as 
possible, and to also provide the surgeon with appropriate tools to gauge if they want to continue 
with the scheduled surgery.  
 The use of A1C measurements in preoperative evaluations has been studied in the 
literature, but the results are not as helpful in the practice setting.  Many providers and 
associations presume the A1C goal should be less than 7% in higher acuity surgical procedures, 
yet there is no clear-cut equation for this. The literature lacks large studies that demonstrate the 
ability to have a precise cut off for the A1C goal in the setting of preoperative evaluations. It was 
also found in the literature that blood glucose monitoring is more reflective of overall surgical 
risk than a target A1C, as blood glucose monitoring shows the current concentration of glucose 
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in the blood. The purpose of this paper and research topic is to further establish our basis of A1C 
measurements prior to surgical procedures and what this means for outcomes in our patients. 
Specifically, a reflection of if a patients A1C is greater than 7% and what that means for their 
poor surgical outcomes, versus if it is a rather loose association to the overall risk.  
 An A1C, or glycosylated hemoglobin, is a blood test that shows what the patients average 
blood glucose was over the past three months (American Diabetes Association, 2020). Results of 
an A1C less than 5.7% are within normal limits, 5.7-6.4% being prediabetes range, and 6.5% or 
greater are within diabetes range. Optimal A1C goals for most individuals with diabetes are less 
than 7% unless they are older and other comorbidities, which then their A1C goals are less 
stringent because of their hypoglycemia risk. A1C measurements assist providers in assessing 
the necessary needs of the patient and how well controlled their diabetes is, as this can impact 
outcomes. The most current literature and guidelines relating to diabetic control prior to surgical 
procedures as having an A1C measurement less than 7%.  
Case Report 
Gender:  Female 
Race: Caucasian 
Language: English 
Historian:  Patient excellent historian 
Chief Complaint: Pre-op examination 
History of Present Illness:  76-year-old female presents to the clinic for a pre-op exam for her R 
knee arthroscopy. She states she had a meniscal tear several months ago and has been having 
some pain with this. She states her pain today is 9/10 in the right knee, which is “not bad.” She 
takes ibuprofen or Tylenol every day and rotates the two.  The date of surgery is not known. She 
states her past surgical history is having had a c-section. She denies any complications with 
anesthesia. No personal or family history of malignant hyperthermia or bleeding/clotting 
disorders. She denies a history of sleep apnea or respiratory disease.  
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ASA II Mallampati: 1 METs: 4 
Current Medications: Lisinopril 10mg daily, metformin 1000mg twice daily, Rybelsus 7mg 
daily, Synthroid 125mcg daily, ASA 81mg daily, APAP 1000mg TID PRN, ibuprofen 600mg 
TID PRN 
Allergies: Morphine, Amoxicillin 
Past Medical History: HTN, hypothyroid, DM 2, obesity, Squamous cell carcinoma 
Past Surgical History: c section x2 
Family History: Father: Prostate Cancer, HTN Mother: Breast cancer, HTN, obesity MaGr: 
Breast cancer  
Social History: Lives at home independently. Uses walker or cane to move around. Denies 
alcohol and illicit drug use. Smoked tobacco for 20 years- 1ppd, quit 5 years ago.  
Review of Systems: No complaints of fever, chills, congestion/runny nose, changes in hearing or 
vision, sore throat, cough, shortness of breath, chest pain, weakness, bleeding, or urine/bowel 
changes. Denies numbness, tingling, or weakness to upper or lower extremities. Chronic pain to 
R knee.  
Physical Examination:   
Vital Signs: HR 78bpm BP 136/88 R 16 RA 96% T 98.6F Ht 66in Wt 211lbs BMI 34 
Constitutional: Oriented x4, well kept 
HEENT: Normocephalic. No lymphadenopathy. R TM intact, pearly grey, no erythema. L TM 
intact, pearly grey, no erythema. No tonsillar exudate, or redness to oropharynx. Uvula midline.  
Cardiovascular: Heart sounds regular, s1 & s2. No murmurs noted. Cap refill <3 sec. No edema 
noted.  
Respiratory: Lung sounds clear in all fields. No rhonchi, crackles, rales, or wheezes heard.  
Musculoskeletal: Pedal and post tib pulses present bilaterally.  
Laboratory/Diagnostic Tests: BMP, CBC, A1C, CXR, EKG 
Diagnosis/diagnoses: 
Preoperative examination 
Essential Hypertension 
Hypothyroid 
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Obesity  
Diabetes type 2 
Management plan (therapeutic decision making):  
A1C: 6.2. CBC, BMP, EKG, CXR to be ordered. Will follow up with results. Educated on medications to 
take and not to take the week before surgery. Hold ASA and ibuprofen/NSAIDs for seven days before 
surgery. Can take Tylenol up to one day prior to surgery, often given prior to surgery. Take thyroid 
medication the morning of surgery. Resume all other medications following surgery. Educated on 
advance care planning-should complete prior to surgery. Educated on risks of having surgery- pulmonary 
embolism, DVT, heart attack, stroke, death. Educated on post-operative DVT/PE monitoring, making sure 
to keep moving, watch bowel movements if taking opioids following surgery. Pt in agreement with plan, 
questions answered. Follow up if symptoms or questions arise. OK to proceed with surgery at this time.  
Literature Search 
 The first search was conducted on CINAHL Complete, Health Source - Consumer 
Edition, Health Source: Nursing/Academic Edition, and MEDLINE Complete via Ebscohost. 
Key words for the search were as follows: (1) “A1C” and (2) “surgery.” The search was 
completed using Boolean phrases of the above quoted items, peer reviewed was selected, dates 
were altered to 2014-2020, full text was selected, and lastly written in English. The search 
resulted in 403 total articles, of which five were pertinent to the posed question with further 
review. The second search was conducted on the Pubmed database. Pubmed provides an even 
larger foundation of nursing research and general guidelines. A search was conducted with the 
key words listed: (1) “A1C” and (2) “surgical outcomes.” The search was further divided into the 
past five years publication date, availability of full text, and available in English. The search 
yielded 2,196 articles, and only five were prevalent to this research question with further review.   
Literature Review and Synthesis of Findings 
 Current literature clearly documents an increased surgical risk with patients who have 
uncontrolled diabetes at the time of surgery. However, this literature is varied in its clinical 
recommendations regarding acceptable A1C levels in the setting of proceeding with an elective 
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surgery. Every patient’s surgical risk is individual and based on many factors including age, co-
morbid conditions, type of anesthesia being used, and type of surgical procedure being done. 
Underwood et al. (2014) conducted a retrospective study that included 449 patients undergoing 
elective procedures with documented A1C measurements prior to their surgery. The article 
concluded that A1C measurements greater than 8% were more likely to increase length of stay 
and that more studies need to be conducted to assess mortality, infections, renal failure, and 
rehospitalization. This is a trend across most of the literature and reflects that A1C measurements 
are important in preoperative evaluations but the exact A1C that displaces the risk into a higher 
category is unidentified. The conclusions from this article are similar to current standards of care, 
however 8% is further from the typical 7% that is recognized and this allows for a larger 
interpretation.   
 Specific to elective surgical procedure risks in the diabetic population, post-operative 
infections are of a high concern. It is well documented that patients with diabetes are at an 
increased risk of infection due to their elevated blood glucose levels. A pertinent systematic 
review and meta-analysis was conducted on diabetic patients and their relation to developing 
surgical site infections after undergoing elective procedures (Martin et al., 2016). The results 
found that there was a higher risk of surgical site infections in patients with diabetes, which led 
to the overall proposal of diabetes being an independent risk factor in the perioperative setting. 
However, a specific A1C recommendation was not made from this research. Contrary to that, a 
separate retrospective study was done on patients undergoing non-emergent procedures that had 
a pre-operative A1C measured, and it was found that infection rates were no different between 
the diabetic group and the non-diabetic group (Blankush et al., 2016). It was speculated that risk 
factors for post-operative infections are likely synergistic rather than causative simply from 
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diabetes. This literature provides the reader with little information on the true impact of A1C 
measurements on surgical site infections. Further subgroups and case by case analysis would be 
more beneficial in understanding the A1C impact on poor surgical outcomes in each of these 
studies, while also demonstrating that diabetes does play a large part in the complete risk for 
these patients. 
 There has also been discussion and literature revolving around blood glucose monitoring 
being of higher priority in the perioperative setting when determining a patient’s risk, rather than 
focusing on A1C measurements alone. This discussion began with a vast observational cohort 
study including 21,541 patients within the Veterans Affair hospital was done that compared the 
association between preoperative A1C and early postoperative glucose levels in patients 
undergoing elective gastrointestinal surgeries (Jones et al., 2017). This demonstrated a lack of 
findings regarding an elevated A1C causing poor surgical outcomes due to the increased blood 
glucose monitoring that these patients undergo. Likewise, a systematic review and meta-analysis 
was completed on 26,901 patients regarding A1C measurements, perioperative hyperglycemia, 
and the predictive nature of periprosthetic joint infection following total joint arthroplasties 
(Yang et al., 2017). The study concluded that hyperglycemia and elevated A1C measurements 
did in fact increase the risk of periprosthetic joint infections. It was further reiterated that the idea 
behind monitoring blood glucose measurement perioperatively is a more predictive and 
reflective aid in infection risk instead of relying solely on A1C measurements. Van den Boom et 
al. (2018) completed a retrospective analysis on 431,480 surgeries completed at Duke Hospital 
and measured the effects of A1C and glucose on postoperative mortality. Their findings were 
similar in that glucose measurements perioperatively were more predictive than A1C 
measurements when looking at 30-day mortality rates. These articles provide a better basis of 
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knowledge concerning where our efforts can impact the patients most. Perioperative blood 
glucose monitoring is very common in the surgical setting with patients who have diabetes, and 
completely independent of their elective or non-elective surgical status. It would make sense that 
perioperative blood glucose control would have the largest impact on poor outcomes in the 
setting of elective surgical procedures.  
 Although previous articles have not determined a specific A1C measurement that 
determines complete risk in diabetic patients undergoing elective procedures, there are still 
studies that do contain this information. An A1C measurement of 8% was decided to be a 
maximum threshold used informally for an independent risk factor in one study relating to 
postoperative infections requiring surgical intervention in patients with diabetes who underwent 
total knee arthroplasties (Cancienne, Werner, & Browne, 2017). They specified that an A1C goal 
of less than 7% did in fact decrease the risk of postoperative infections in this patient subgroup 
exclusively. It was also identified that previously completed studies were much smaller in the 
number of patients included, which has created a barrier in understanding the true risk of each of 
the A1C measurements compared to poor outcomes.  
A1C measurements greater than 7% were found to cause a definite increase in surgical 
site infection risks (Showen et al., 2017). The general consensus reiterated that perioperative 
glucose monitoring was again found to more beneficial in decreasing risk, instead of a sole A1C 
focus. A specific study established that having an A1C greater than 6.9% was found to increase 
risk of infection rates among patients who underwent a single-level lumbar posterior fusion 
(Hwang et al., 2019) However, this study contained only 92 participants, which creates a large 
barrier to applying as a guideline with such a small sample size and specific surgical procedure. 
Statz et al. (2018) considered outcomes of shoulder arthroplasties of 406 patients and their 
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perioperative A1C measurements. Their findings consisted of a poor correlation between A1C 
measurements and poor surgical outcomes following shoulder arthroplasties. It was still advised 
that this lab be checked and optimized prior to surgery but further studies need to be conducted 
to give a clear cut off of A1C goals.  
 The case study patient presented earlier in the paper had an A1C of 6.2% and was being 
managed on metformin and rybelsus. This A1C measurement is very ideal for surgical 
optimization reflection purposes. This meant that her diabetes was not interfering with upcoming 
surgery by simply relying on this measurement. The findings from the literature review were vast 
in nature, yet very similar. Most of the articles found that specific A1C cutoffs were not 
necessarily correlating to the measured risks, but elevated A1C’s were contributing to a general 
increase of poor surgical outcomes. The A1C levels that were greater than 7% were found to 
increase risk, but to what degree still remains to be studied. The literature reiterated that  
perioperative glucose monitoring would be the most beneficial to patients, rather than basing it 
completely on A1C goals. Further studies need to be conducted to find a correlation between 
specific A1C numbers and their results following surgical procedures. A common limitation for 
each of the articles was the vast majority of patients have other comorbidities and it is difficult to 
pinpoint an A1C measurement as a strict reflection of their poor surgical outcome risk. The most 
prevalent risk factor included surgical site infection, which was most often correlated with an 
increased A1C. However, glucose monitoring in the perioperative setting will be very beneficial 
while awaiting further studies.  
Learning Points 
• Perioperative glucose has a much higher predictive clinical value in patients with diabetes 
who undergo elective surgical procedures than is reflective of their A1C measurements.  
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• A1C is recommended to be optimized in most situations, with several sources finding 
measurements greater than 7% do increase the risk of poor surgical outcomes in elective 
procedures. However, the degree of the exact A1C measurement was found to be relative 
in that it is not a direct reflection but a contributor to risk.  
• Each patient is an individual and their risks need to be weighed at the time of their office 
visit, as well as each surgical procedure carrying their own independent risks.  
Conclusion 
 This paper looked to evaluate what correlation exists between patients with type 2 
diabetes and their increased surgical risks if their A1C was >7%. The literature review and 
synthesis of findings led to the conclusion that A1C measurements are ideal to be taken prior to 
surgery, but the perioperative glucose measurements are much more conducive to decreasing 
overall poor surgical outcomes. There is a risk associated with A1C levels greater than 7% in 
patients undergoing elective surgical procedures, but the degree of risk if unknown and likely to 
be multifactorial. This can impact the future of medicine, yet requires a perioperative plan to be 
in place of checking blood sugars to a target goal. The target goal of blood sugars and A1C 
measurements in regards to perioperative management have yet to be decided for current 
reference, which will require a need for further studies to be conducted.  
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